Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.
- befree-2016 importedOn "2016-02-19" NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.
- NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_assertion wasGeneratedBy ECO_0000203 NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.
- NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_assertion wasDerivedFrom befree-2016 NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.
- NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_assertion SIO_000772 20520640 NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.
- NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_assertion evidence source_evidence_literature NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.
- NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_assertion description "[Gene set enrichment analysis (GSEA) of the NF-kappaB target genes and 4394 additional gene sets covering various cellular pathways, biological processes and molecular functions have shown that translocation-positive MALT lymphomas are characterized by an enhanced expression of NF-kappaB target genes, particularly toll like receptor (TLR)6, chemokine, CC motif, receptor (CCR)2, cluster of differentiation (CD)69 and B-cell CLL/lymphoma (BCL)2, while translocation-negative cases were featured by active inflammatory and immune responses, such as interleukin-8, CD86, CD28 and inducible T-cell costimulator (ICOS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816329.RA5H90emydG_jT1OXRwPyJjLtUdEi-I_3CG0FG1jpg7FY130_provenance.